Skip to main content

Table 3 Adjusted HR of number of MS components associated with CVD

From: The Association of Metabolic Syndrome with the development of cardiovascular disease among Kazakhs in remote rural areas of Xinjiang, China: a cohort study

 

CVD (n)

Incidence of CVD, (%)

HR (95%CI)

aHR** (95%CI)

0 component

17

5.56

1.00 (reference)

1.00 (reference)

1 component*

62

10.25

1.82 (1.07–3.11)

1.49 (0.87–2.55)

2 components*

85

15.02

2.86 (1.70–4.82)

1.76 (1.03–2.99)

3 components*

60

17.96

3.58 (2.09–6.13)

1.89 (1.08–3.29)

4 components*

36

24.66

5.68 (3.19–10.12)

2.56 (1.41–4.65)

5 components*

18

37.50

8.59 (4.43–16.67)

4.25 (2.16–8.39)

P for trend

  

< 0.001

< 0.001

  1. *Compared with those with 0 components of MS; HR, univariate analysis; **adjusted for age, sex, drinking, and family history of hypertension, diabetes, and CVD; Abbreviations are defined in Tables 1 and 2